Outset Medical
73 hedge funds and large institutions have $23.4M invested in Outset Medical in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 16 closing their positions.
118% more call options, than puts
Call options by funds: $159K | Put options by funds: $73K
33% more capital invested
Capital invested by funds: $17.6M → $23.4M (+$5.75M)
0.66% less ownership
Funds ownership: 3.33% → 2.67% (-0.66%)
6% less funds holding
Funds holding: 78 → 73 (-5)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$526K |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
+$299K |
| 3 |
Morgan Stanley
New York
|
+$210K |
| 4 |
Squarepoint
New York
|
+$130K |
| 5 |
Two Sigma Investments
New York
|
+$108K |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.23M |
| 2 |
MIC
Mubadala Investment Company
Abu Dhabi,
United Arab Emirates
|
-$975K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$917K |
| 4 |
Millennium Management
New York
|
-$412K |
| 5 |
D.E. Shaw & Co
New York
|
-$290K |
OM Hedge Fund Activity: Q4 2024 in Review
73 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2024, worth a combined $23.4M — up 33% from $17.6M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of OM and 12 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 16 added.
The largest buyer was Renaissance Technologies, adding an estimated $526K. The largest seller was Ameriprise, exiting entirely with an estimated $1.23M sold.
- 73 institutional investors held Outset Medical (OM) as of Q4 2024, down from 78 in Q3 2024.
- Funds reported $23.4M of Outset Medical stock for Q4 2024, up 33% quarter-over-quarter.
- 12 funds opened new Outset Medical positions in Q4 2024 and 16 closed out, a net change of -4 holders.
- The largest Outset Medical buyer in Q4 2024 was Renaissance Technologies, an estimated $526K added.
- The largest Outset Medical seller in Q4 2024 was Ameriprise, an estimated $1.23M sold.
Based on aggregated 13F filings for Q4 2024.